Dr. Bowlus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 V St
Ste 3500
Sacramento, CA 95817Phone+1 916-734-3751Fax+1 916-734-7908
Education & Training
- Yale-New Haven Medical CenterFellowship, Gastroenterology, 1993 - 1996
- University of California Davis HealthResidency, Internal Medicine, 1990 - 1993
- Saint Louis University School of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 1991 - 2027
- CT State Medical License 1993 - 1999
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (FAASLD) American Association for the Study of Liver Disease
- Fellow (AGAF) American Gastroenterological Association, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Initial Study of Rituximab to Treat Primary Biliary Cirrhosis Start of enrollment: 2007 Jan 01
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease Start of enrollment: 2007 Oct 01
- Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis.Connie Chan, Mateus Lemos, Peter Finnegan, William Gagnon, Richard Dean
JHEP Reports. 2024-12-01 - Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.Kris V Kowdley, Gideon M Hirschfield, Charles Coombs, Elizabeth S Malecha, Leona Bessonova
The American Journal of Gastroenterology. 2024-11-29 - Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease...Hannah Bloemen, Alexandra E Livanos, Adrielly Martins, Richard Dean, Ana Catarina Bravo
Clinical Gastroenterology and Hepatology. 2024-10-25
Lectures
- 2013 UC Davis Update in Gastroenterology and HepatologyUC Davis Health System, Monterey, California - 8/24/2013
- 31st Annual UC Davis Infectious Diseases Conference,2013UC Davis Health System, Sacramento, California - 2/1/2013
- 2012 Update in Gastroenterology & Hepatology for the Primary Care PractitionerUC Davis Health System, Olympic Valley, California - 8/18/2012
Press Mentions
- Oral Presentation at AASLD the Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing CholangitisNovember 19th, 2024
- Meet Antonio Mendoza-Ladd, UC Davis Health’s New Medical Director of EndoscopyFebruary 23rd, 2023
- CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate UpdateNovember 14th, 2022
- Join now to see all
Grant Support
- Oxidative Mutagenesis:Iron, Ascorbic Acid And GenesNational Institute Of Environmental Health Sciences2001–2002
- Cloning Of The Hemochromatosis LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
- Cloning Of The Hemochromatosis LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
Professional Memberships
- Fellow
- American Association for the Study of Liver DiseaseFellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: